Isotopen Technologien Munchen AG

ITM is a biotechnology company that develops and markets radiopharmaceuticals and radionuclides for the treatment of cancers. Read more

3 Followers on Owler
3 Followers on Owler
3 Followers on Owler
3 Followers on Owler

Isotopen Technologien Munchen AG

ITM is a biotechnology company that develops and markets radiopharmaceuticals and radionuclides for the treatment of cancers. Read more

Steffen Schuster's photo - CEO of Isotopen Technologien Munchen AG

CEO

Steffen Schuster

CEO Approval Rating

90/100

Founded:

2004

Status:

PrivateIndependent Company

ISOTOPEN TECHNOLOGIEN MUNCHEN AG TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Alliance Medical is Isotopen Technologien Munchen AG's top competitor. Alliance Medical was founded in 1989 in Warwick, England. Alliance Medical competes in the Health Care Technology field. Alliance Medical generates $162M more revenue than Isotopen Technologien Munchen AG.

Trasis S.A. is perceived as one of Isotopen Technologien Munchen AG's biggest rivals. Trasis S.A.'s headquarters is in Ans, Liège, and was founded in 2004. Trasis S.A. is in the Biotechnology industry. Trasis S.A. generates NaN% of Isotopen Technologien Munchen AG's revenue.

Advanced Accelerator Applications is one of Isotopen Technologien Munchen AG's top competitors. Advanced Accelerator Applications is a Private company that was founded in Saint-Genis-Pouilly, Other in 2002. Like Isotopen Technologien Munchen AG, Advanced Accelerator Applications also operates in the Health Care Services industry. Advanced Accelerator Applications has 975 more employees vs. Isotopen Technologien Munchen AG.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $ < 1M a good estimate for Isotopen Technologien Munchen AG's revenue?

Isotopen Technologien Munchen AG Acquisitions

No recent acquisitions found related to Isotopen Technologien Munchen AG

Isotopen Technologien Munchen AG Funding History

Since Isotopen Technologien Munchen AG was founded in 2004, it has participated in 2 rounds of funding. In total Isotopen Technologien Munchen AG has raised $65.7M. Isotopen Technologien Munchen AG's last funding round was on Feb 2020 for a total of $43.7M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Feb 2020
$43.7M
Unattributed
Mar 2016
$22M
-

Since Isotopen Technologien Munchen AG was founded in 2004, it has participated in 2 rounds of funding. In total Isotopen Technologien Munchen AG has raised $65.7M. Isotopen Technologien Munchen AG's last funding round was on Feb 2020 for a total of $43.7M

Isotopen Technologien Munchen AG Investments

No recent investments found related to Isotopen Technologien Munchen AG

Isotopen Technologien Munchen AG News

March 2, 2020firstwordpharma

ITM expands PSMA-617 supply agreement for no-carrier-added Lutetium-177

ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companie... See more »
February 12, 2020FirstWord Pharma

European Investment Bank provides funding of €40 million to ITM

Funds will support ITM’s research and development strategy for cancer treatments... See more »
November 25, 2019FinanzNachrichten

ITM Receives German Medical Award 2019 for the Most Innovative Product

ITM wins German Medical Award in the category "Medical Innovation Product" for outstanding patient be... See more »
November 18, 2019Medical Buyer

ITM And CIRC Sign Technology License Agreement

MUNICH & GARCHING,Germany-ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharma... See more »
October 7, 2019BioPortfolio

ITM Signs Longterm Supply Agreements With Nordic Nanovector for Nocarrieradded Lutetium177

ITM Isotopen Technologien Mnchen AG ITM a biotechnology and radiopharmaceutical group of companies an... See more »
October 7, 2019Contract Pharma

Nordic Nanovector, Isotope Technologies Enter Supply Pact

Extend global supply agreement for n.c.a. Lutetium-177 (EndolucinBeta)... See more »
September 30, 2019BioSpace

ITM and Bruce Power Successfully Complete Feasibility Study

Key requirements met to start Ytterbium-176 irradiation at Bruce Power's facilities for the productio... See more »

Isotopen Technologien Munchen AG Press Releases

Isotopen Technologien Munchen AG Videos

Social Media

Isotopen Technologien Munchen AG Headquarters

Lichtenbergstrasse 1

Garching bei München, Bavaria85748

49-89-329-8986-600

Driving Directions »

Trending Companies

Isotopen Technologien Munchen AG Summary

ABOUT

Overview

ITM is a biotechnology company that develops and markets radiopharmaceuticals and radionuclides for the treatment of cancers. Isotopen Technologien Munchen AG was founded in 2004. Isotopen Technologien Munchen AG's headquarters is located in Garching ...

CEO

Isotopen Technologien Munchen AG's CEO, Steffen Schuster, currently has an approval rating of 90%. Isotopen Technologien Munchen AG's primary competitors are Alliance Medical, Trasis S.A. & Advanced Accelerator Applications.

Website

isotope-technologies-munich.com

Frequently Asked Questions about Isotopen Technologien Munchen AG

  1. When was Isotopen Technologien Munchen AG founded?

    Isotopen Technologien Munchen AG was founded in 2004
  2. Who is Isotopen Technologien Munchen AG's CEO?

    Isotopen Technologien Munchen AG's CEO is Steffen Schuster
  3. How much revenue does Isotopen Technologien Munchen AG generate?

    Isotopen Technologien Munchen AG generates $ < 1M in revenue
  4. How much funding does Isotopen Technologien Munchen AG have?

    Isotopen Technologien Munchen AG has historically raised $65.7M in funding
  1. Where is Isotopen Technologien Munchen AG's headquarters?

    Isotopen Technologien Munchen AG's headquarters is in Garching bei München Bavaria, DE
  2. How many employees does Isotopen Technologien Munchen AG have?

    Isotopen Technologien Munchen AG has 25 employees
  3. What sector does Isotopen Technologien Munchen AG operate in?

    Isotopen Technologien Munchen AG is in Health Care Services
  4. Who are Isotopen Technologien Munchen AG's competitors?

    Isotopen Technologien Munchen AG's top competitors are Alliance Medical, Trasis S.A., Advanced Accelerator Applications